Regeneron Announces Upcoming Investor Conference Presentations
Guggenheim Healthcare Talks Idea Forum, Neuro/Immunology Day, at 11:15 a.m. ESTon Monday, November 18, 2019 Piper Jaffray31st Annual Healthcare Conference at 8:00 a.m. ESTon Tuesday, December 3, 2019
The sessions may be accessed from the "Investors & Media" page of Regeneron's website at http://investor.regeneron.com/events-and-presentations. Replays of the webcasts will be archived on the Company's website for at least 30 days.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven
Regeneron is accelerating and improving the traditional drug development process through its proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.